The Lunaphore Immuno-Oncology Grant Program has been designed with the intention of helping in the research of immuno-oncology by providing innovative instruments based on a microfluidic technology to perform mIF staining. Dr. Rahman and Chowdhury Arif Jahangir won 1st prize for a project titled “Exploration of the Interplay between Master Transcriptional Regulators and Immune Cells within the Tumour Microenvironment of Breast Cancer AND Comparison of subcutaneous adipose tissue (SAT) inflammatory profiles in individuals with and without COVID-19 infection” is a LabSat® Research system. This system which offers ultra-rapid turnover time for multiplex staining, and will be embedded in the Precision Oncology Ireland tissue imaging platform.
-
Cancer Research News- NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients April 18, 2024
- For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life March 7, 2024
- Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges March 6, 2024
- NIH to address dwindling clinical trial patient enrollment with centralized staffing support February 29, 2024
- NIH launches research network to evaluate emerging cancer screening technologies February 21, 2024
- W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute December 18, 2023
- NCI researchers develop approach that could help supercharge T-cell therapies against solid tumors November 1, 2023
- NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation October 24, 2023
- Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic September 27, 2023
- NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries August 14, 2023